NCT05912244 2026-06-01A Study of IO102/IO103, Nivolumab, and Relatlimab in People With MelanomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting43 enrolled
NCT05418972 2026-02-05Neo ReNi IIMelanoma Institute AustraliaPhase 2 Active not recruiting20 enrolled